Health ProductsType I recall

APO-AMITRIPTYLINE 10mg: NDMA impurity

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: APO-AMITRIPTYLINE 10mg
Issue: Health products - Product safety
What to do: Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Contact your health care provider if you have taken a recalled product and you have concerns about your health.
Audience: General public, Health professionals, Hospitals
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Product NameDosage FormLotBrandMarket AuthorizationStrength
APO-AMITRIPTYLINE 10mgTabletPY1832ApotexDIN 02403137AMITRIPTYLINE HYDROCHLORIDE 10mg

Issue

Affected lots exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime